Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Perrone

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
The Biochemical Journal|April 16, 1998
Transient overexpression of human H- and L-ferritin chains in COS cellsB Corsi, F Perrone, M Bourgeois, et al.
British Journal of Cancer|May 1, 1996
A predictive index of axillary nodal involvement in operable breast cancerM De Laurentiis, C Gallo, S De Placido, et al.
British Journal of Cancer|January 16, 2014
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerS Zanutto, S Pizzamiglio, M Ghilotti, et al.
European Journal of Gynaecological Oncology|January 1, 1991
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study)A R Bianco, R Rosso, F Calabresi, et al.
Breast Cancer Research and Treatment|September 1, 1990
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) StudyS De Placido, C Gallo, A Marinelli, et al.
Anticancer Research|January 29, 2000
Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trialC Gridelli, F Perrone, C Gallo, et al.
Tumori|January 1, 1995
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples ProvinceS de Placido, F Nuzzo, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts PanelC Gridelli, A Ardizzoni, T Le Chevalier, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2012
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patientsF Pietrantonio, P Biondani, M Milione, et al.
Oncology|January 25, 2000
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 studyS De Placido, R Lauria, F Perrone, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
The Biochemical Journal|April 16, 1998
Transient overexpression of human H- and L-ferritin chains in COS cellsB Corsi, F Perrone, M Bourgeois, et al.
British Journal of Cancer|May 1, 1996
A predictive index of axillary nodal involvement in operable breast cancerM De Laurentiis, C Gallo, S De Placido, et al.
British Journal of Cancer|January 16, 2014
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerS Zanutto, S Pizzamiglio, M Ghilotti, et al.
European Journal of Gynaecological Oncology|January 1, 1991
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study)A R Bianco, R Rosso, F Calabresi, et al.
Breast Cancer Research and Treatment|September 1, 1990
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) StudyS De Placido, C Gallo, A Marinelli, et al.
Anticancer Research|January 29, 2000
Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trialC Gridelli, F Perrone, C Gallo, et al.
Tumori|January 1, 1995
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples ProvinceS de Placido, F Nuzzo, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts PanelC Gridelli, A Ardizzoni, T Le Chevalier, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2012
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patientsF Pietrantonio, P Biondani, M Milione, et al.
Oncology|January 25, 2000
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 studyS De Placido, R Lauria, F Perrone, et al.
Pageof 19